Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas K. Equels currently holds 492,919 shares of HEMISPHERX BIOPHARMA INC (HEB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas K. Equels has been a net buyer of HEB stock. They have purchased $347.8K and sold $0 worth of shares.
Thomas K. Equels's most recent insider trade was on Apr 27, 2017, when they purchased 72,464 shares at $0.69 per share.
Thomas K. Equels serves as Executive at HEMISPHERX BIOPHARMA INC (HEB). They have executed 31 insider transactions totaling $347.8K over their tenure at the company.
Thomas K. Equels holds the position of Executive at HEMISPHERX BIOPHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Thomas K. Equels has shown a buying trading pattern, with $347.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Thomas K. Equels was on Feb 19, 2009, when they purchased $150.0K worth of HEB shares. This transaction involved 375,000 shares at $0.40 per share.
Thomas K. Equels currently owns 492,919 shares of HEMISPHERX BIOPHARMA INC (HEB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas K. Equels's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas K. Equels has 31 Form 4 filings on record as an insider at HEMISPHERX BIOPHARMA INC.
Set alerts for Thomas K. Equels and 40,000+ other insiders.